This site is intended for healthcare professionals only
LoginRegister
Health Ministry Proposes New Rules for Post-Approval Drug Manufacturing, Quality ChangesGujarat Expands Essential Drug List to 1,479 Medicines, 150 Added, 57 Removed
Granules Indias US Packaging Facility Secures USFDA EIR with Zero ObservationsGranules India's US Packaging Facility Secures USFDA EIR with Zero Observations
Indian Pharma Faces Rs 5,000 Crore Export Risk as Middle East Conflict Drives Freight Charges UpIndian Pharma Faces Rs 5,000 Crore Export Risk as Middle East Conflict Drives Freight Charges Up
USFDA Approves Johnson and Johnson Blood Cancer Drug Tecvayli-Darzalex ComboUSFDA Approves Johnson and Johnson's Blood Cancer Drug Tecvayli-Darzalex Combo via Fast-Track...
South Africa Pushes for Local Manufacturing of Gileads HIV Drug Lenacapavir to Boost AccessSouth Africa Pushes for Local Manufacturing of Gilead's HIV Drug Lenacapavir to Boost Access
USFDA Flags Aurobindos Eugia Unit-II with OAI Status After Bhiwadi InspectionAurobindo Subsidiary Eugia Launches Generic Pomalyst Capsules in US
Sanofis Diabetes Drug Lantus SoloStar Insulin Batch Stolen, CDSCO Issues AlertSanofi's Diabetes Drug Lantus SoloStar Insulin Batch Stolen, CDSCO Issues Alert
Pharma Firm Blacklisted in Goa Over Alleged Spurious Anti-Snake Venom SupplyPharma Firm Blacklisted in Goa Over Alleged Spurious Anti-Snake Venom Supply
Natco PharmaNatco Pharma Enters USD 3.2 Billion US Pomalidomide Market, Claims 180-Day Exclusivity
Caplin Steriles Secures USFDA Nod for Generic DEPO-MEDROL InjectionCaplin Steriles Secures USFDA Nod for Generic DEPO-MEDROL Injection
USFDA Pushes Shift from Animal Testing, Draft Guidance Backs AI and Human-Based Drug ResearchUSFDA Operations Chief Barclay Butler to Retire, Veteran Melanie Keller to Take Charge
Indias Semaglutide Market Set for Generic Boom as Patents Expire, Over 50 Brands Lined Up for Launch, See Full ListIndia's Semaglutide Market Set for Generic Boom as Patents Expire, Over 50 Brands Lined Up for...
X